Summary: Week of 11/23/24
After a break over the Thanksgiving holiday, we are updating our report with data through November 23rd. We’ll give an additional update with more recent data later this week.
Biobot’s national wastewater network shows that SARS-CoV-2 levels are low and continue to hold steady in week 47, while RSV and influenza continue to increase. National hospitalizations for COVID-19 continue to decline, currently at 1 per 100,000 people in week 47. National hospitalizations for RSV and influenza are increasing, but are still low, currently at 0.9 and 0.3 per 100,000 people in week 47, respectively.
The Bottom Line: RSV and influenza are increasing. As we head into the holiday season and social gatherings increase, it’s good to remember these recommendations to stay healthy: stay current with vaccinations and boosters, consider wearing a mask in crowded areas, and if you feel unwell, minimize contact with others.
National Outlook
COVID-19
SARS-CoV-2 concentrations are holding steady at low levels nationally.
Influenza
Despite some fluctuations, national influenza A and B concentrations are increasing.
RSV
National RSV concentrations are increasing.
Regional
The South
COVID-19: SARS-CoV-2 concentrations are holding steady in the South.
Influenza: Influenza A and B concentrations are fluctuating at low levels in the South.
RSV: RSV concentrations are increasing in the South.
The Midwest
COVID-19: SARS-CoV-2 concentrations are holding steady in the Midwest.
Influenza: Influenza A and B concentrations are holding steady in the Midwest.
RSV: RSV concentrations are increasing in the Midwest.
The Northeast
COVID-19: SARS-CoV-2 concentrations are holding steady in the Northeast.
Influenza: Influenza A and B concentrations are fluctuating at low levels in the Northeast.
RSV: RSV concentrations are increasing in the Northeast.
The West
COVID-19: SARS-CoV-2 concentrations are slightly increasing in the West.
Influenza: Influenza A and B concentrations are increasing in the West.
RSV: RSV concentrations are increasing in the West.
Footnotes:
We continue to monitor the evolving H5N1 influenza virus situation. As we do, a quick reminder that Biobot’s influenza A assay detects the H5N1 influenza subtype, which is an influenza A virus, but does not distinguish between the different subtypes of influenza A (e.g. H5N1 vs H1N1). We will share any important updates as we have them via Twitter and Bluesky, and in the risk reports.
Wastewater data from Biobot Analytics for RSV, influenza, and SARS-CoV-2 are through November 23, 2024 (MMWR week 47). Clinical data for RSV, influenza, and COVID-19 are from the Centers for Disease Control and Prevention. Updates to clinical data are through November 23, 2024 (MMWR week 47).